The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Ventricular Fibrillation

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Ventricular Fibrillation


Psychiatry related information on Ventricular Fibrillation


High impact information on Ventricular Fibrillation


Chemical compound and disease context of Ventricular Fibrillation


Biological context of Ventricular Fibrillation


Anatomical context of Ventricular Fibrillation


Gene context of Ventricular Fibrillation


Analytical, diagnostic and therapeutic context of Ventricular Fibrillation


  1. Clinical efficacy and electrophysiology during long-term therapy for recurrent ventricular tachycardia or ventricular fibrillation. Heger, J.J., Prystowsky, E.N., Jackman, W.M., Naccarelli, G.V., Warfel, K.A., Rinkenberger, R.L., Zipes, D.P. N. Engl. J. Med. (1981) [Pubmed]
  2. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Abbott, G.W., Sesti, F., Splawski, I., Buck, M.E., Lehmann, M.H., Timothy, K.W., Keating, M.T., Goldstein, S.A. Cell (1999) [Pubmed]
  3. Bretylium tosylate: a newly available antiarrhythmic drug for ventricular arrhythmias. Heissenbuttel, R.H., Bigger, J.T. Ann. Intern. Med. (1979) [Pubmed]
  4. Cumulative epinephrine dose during cardiopulmonary resuscitation and neurologic outcome. Behringer, W., Kittler, H., Sterz, F., Domanovits, H., Schoerkhuber, W., Holzer, M., Müllner, M., Laggner, A.N. Ann. Intern. Med. (1998) [Pubmed]
  5. An animal model to examine the response to environmental stress as a factor in sudden cardiac death. Parker, G.W., Michael, L.H., Entman, M.L. Am. J. Cardiol. (1987) [Pubmed]
  6. Anomalous origin of the left coronary artery from the pulmonary artery: new electrocardiographic, echocardiographic and surgical observations. Glaser, J., Rosenman, D., Balkin, J., Zion, M.M., Yakirevich, V., Vidne, B. The Journal of cardiovascular surgery. (1986) [Pubmed]
  7. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. Meredith, I.T., Broughton, A., Jennings, G.L., Esler, M.D. N. Engl. J. Med. (1991) [Pubmed]
  8. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. Rydén, L., Ariniego, R., Arnman, K., Herlitz, J., Hjalmarson, A., Holmberg, S., Reyes, C., Smedgård, P., Svedberg, K., Vedin, A., Waagstein, F., Waldenström, A., Wilhelmsson, C., Wedel, H., Yamamoto, M. N. Engl. J. Med. (1983) [Pubmed]
  9. Tyrosine administration decreases vulnerability to ventricular fibrillation in the normal canine heart. Scott, N.A., DeSilva, R.A., Lown, B., Wurtman, R.J. Science (1981) [Pubmed]
  10. Neuropsychological sequelae of cardiac arrest. Roine, R.O., Kajaste, S., Kaste, M. JAMA (1993) [Pubmed]
  11. Lidocaine to prevent ventricular fibrillation: easy does it. Lown, B. N. Engl. J. Med. (1985) [Pubmed]
  12. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion presssure. Kette, F., Weil, M.H., Gazmuri, R.J. JAMA (1991) [Pubmed]
  13. Caffeine and ventricular arrhythmias. An electrophysiological approach. Chelsky, L.B., Cutler, J.E., Griffith, K., Kron, J., McClelland, J.H., McAnulty, J.H. JAMA (1990) [Pubmed]
  14. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. Corr, P.B., Creer, M.H., Yamada, K.A., Saffitz, J.E., Sobel, B.E. J. Clin. Invest. (1989) [Pubmed]
  15. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death. Hammon, J.W., Oates, J.A. Circulation (1986) [Pubmed]
  16. Verapamil and tiapamil in prevention of ventricular fibrillation in pigs with coronary ligation. Comparative effects on left ventricular function. Muller, C.A., Opie, L.H., Hamm, C.W., Peisach, M., Pineda, C.A., Thandroyen, F.T. Circulation (1988) [Pubmed]
  17. Preservation of ventricular function by treatment of ventricular fibrillation with phenylephrine. Midei, M.G., Sugiura, S., Maughan, W.L., Sagawa, K., Weisfeldt, M.L., Guerci, A.D. J. Am. Coll. Cardiol. (1990) [Pubmed]
  18. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death. De Bruin, M.L., Pettersson, M., Meyboom, R.H., Hoes, A.W., Leufkens, H.G. Eur. Heart J. (2005) [Pubmed]
  19. Short QT syndrome. Schimpf, R., Wolpert, C., Gaita, F., Giustetto, C., Borggrefe, M. Cardiovasc. Res. (2005) [Pubmed]
  20. Modification of ventricular fibrillation latency following coronary artery occlusion in the conscious pig. Skinner, J.E., Lie, J.T., Entman, M.L. Circulation (1975) [Pubmed]
  21. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Westlin, W., Mullane, K. Circulation (1988) [Pubmed]
  22. The effect of chemical ablation of the endocardium on ventricular fibrillation threshold. Damiano, R.J., Smith, P.K., Tripp, H.F., Asano, T., Small, K.W., Lowe, J.E., Ideker, R.E., Cox, J.L. Circulation (1986) [Pubmed]
  23. Defibrillator electrode-chest wall coupling agents: influence on transthoracic impedance and shock success. Aylward, P.E., Kieso, R., Hite, P., Charbonnier, F., Kerber, R.E. J. Am. Coll. Cardiol. (1985) [Pubmed]
  24. Ventricular fibrillation induced by transesophageal atrial pacing in hypertrophic cardiomyopathy. Favale, S., Di Biase, M., Rizzo, U., Minafra, F., Rizzon, P. Eur. Heart J. (1987) [Pubmed]
  25. Inherited arrhythmic disorders in Japan. Hiraoka, M. J. Cardiovasc. Electrophysiol. (2003) [Pubmed]
  26. Two components of delayed rectifier K+ current in heart: molecular basis, functional diversity, and contribution to repolarization. Cheng, J.H., Kodama, I. Acta Pharmacol. Sin. (2004) [Pubmed]
  27. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts. Hirata, A., Minamino, T., Asanuma, H., Sanada, S., Fujita, M., Tsukamoto, O., Wakeno, M., Myoishi, M., Okada, K., Koyama, H., Komamura, K., Takashima, S., Shinozaki, Y., Mori, H., Tomoike, H., Hori, M., Kitakaze, M. Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy. (2005) [Pubmed]
  28. The role of heme oxygenase-related carbon monoxide and ventricular fibrillation in ischemic/reperfused hearts. Bak, I., Papp, G., Turoczi, T., Varga, E., Szendrei, L., Vecsernyes, M., Joo, F., Tosaki, A. Free Radic. Biol. Med. (2002) [Pubmed]
  29. Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. Woodward, B., Zakaria, M.N. J. Mol. Cell. Cardiol. (1985) [Pubmed]
  30. Intramuscular lidocaine for prevention of lethal arrhythmias in the prehospitalization phase of acute myocardial infarction. Koster, R.W., Dunning, A.J. N. Engl. J. Med. (1985) [Pubmed]
  31. Angiotensin II augments reflex activity of the sympathetic nervous system during cardiopulmonary resuscitation in pigs. Lindner, K.H., Prengel, A.W., Pfenninger, E.G., Lindner, I.M. Circulation (1995) [Pubmed]
  32. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Lindner, K.H., Prengel, A.W., Pfenninger, E.G., Lindner, I.M., Strohmenger, H.U., Georgieff, M., Lurie, K.G. Circulation (1995) [Pubmed]
WikiGenes - Universities